August 28, 2025 04:55 AM GMT Mindray Bio-Medical | Asia Pacific Earnings Call Takeaways: Deepening Strategy in "Equipment + Digitalization+ Reccurrence" to Drive Sustainability Key Takeaways See our earnings first take Overseas sales to maintain 10%+ CAGR, with EM at 15%+ near term: EM accounts for 70% of overseas revenue and has a similar sales model to China. Mindray has 13.2% share in equipment and 5.4% in IVD in EM, much lower than in China, suggesting ample room to expand. In DM, high-end client penetr ...